Disseminated paracoccidioidomycosis with meningitis without pulmonary involvement
DOI:
https://doi.org/10.5935/2764-734X.e20250249Keywords:
Central Nervous System, Toxoplasmosis Cerebral;, Paracoccidioidomycosis, Acquired Immunodeficiency Syndrome, Case ReportAbstract
Paracoccidioidomycosis is the most common deep mycosis in Latin America, but it is uncommon in people living with HIV/AIDS, particularly neuroparacoccidioidomycosis. This study reports the case of a 33-year-old man, infected with HIV and with severe immunosuppression. The patient presented the “mixed form” of paracoccidioidomycosis, defined by the concomitant presence of acute/subacute and chronic forms, however without pulmonary involvement. The main differential in this context was cerebral toxoplasmosis, with the final diagnosis being obtained by histological analysis of the lymph node and oral mucosa, as well as through an immunological reaction in the cerebrospinal fluid.
References
1. Plank R, Dean D. Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microbes Infect. 2000;2(10):1265-76. DOI: 10.1016/s1286-4579(00)01280-6
2. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Coordenação-Geral de Desenvolvimento da Epidemiologia em Serviços. Guia de Vigilância em Saúde: volume único, Capítulo 10 – Leptospirose [Internet]. 3ª ed. Brasília: MS; 2019; [cited 2024 Jan 31]. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_3ed.pdf
3. Hotez PJ, Fujiwara RT. Brazil’s neglected tropical diseases: an overview and a report card. Microbes Infect. 2014;16(8):601-6. DOI: 10.1016/j.micinf.2014.07.006
4. Martins MHDM, Spink MJP. Human leptospirosis as a doubly neglected disease in Brazil. Cien Saude Colet. 2020;25(3):919-928. DOI: 10.1590/1413-81232020253.16442018
5. Ministério da Saúde (BR). Sistema de Informação de Notificação de Agravos (SINAN) [Internet]. Brasília: MS; 2007; [cited 2022 Feb 04]. Available from: https://datasus.saude.gov.br/
6. Togal T, Sener A, Yucel N, Demirbilek S, Akgun FS, Aydogan M, et al. Intensive care of a weils disease with multiorgan failure. J Clin Med Res. 2010;2(3):145-9. DOI: 10.4021/jocmr2010.05.302w
7. de Brito T, Silva AMGD, Abreu PAE. Pathology and pathogenesis of human leptospirosis: a commented review. Rev Inst Med Trop Sao Paulo. 2018;60:e23. DOI: 10.1590/s1678-9946201860023
8. Medeiros FR, Spichler A, Athanazio DA. Leptospirosis-associated disturbances of blood vessels, lungs and hemostasis. Acta Trop. 2010;115(1-2):155-62. DOI: 10.1016/j.actatropica.2010.02.016
9. Pereira JCB, Grijó A, Mackay MCB, Vitral BG. Leptospirose pulmonar. Rev Port Pneumol. 2007;13(6):827-39. DOI: 10.1016/S0873-2159(15)30378-0
10. Marotto PC, Ko AI, Murta-Nascimento C, Seguro AC, Prado RR, Barbosa MC, et al. Early identification of leptospirosis-associated pulmonary hemorrhage syndrome by use of a validated prediction model. J Infect. 2010;60(3):218-23. DOI: 10.1016/j.jinf.2009.12.005
11. Park JA. Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis. Int J Mol Sci. 2021;22(2):793. DOI: 10.3390/ijms22020793
12. Daher EDF, Abreu KLS de, Silva Junior GB da. Insuficiência renal aguda associada à leptospirose. Braz J Nephrol. 2010;32(4):408-15. DOI: 10.1590/S0101-28002010000400010
13. Chancharoenthana W, Leelahavanichkul A, Schultz MJ, Dondorp AM. Going Micro in Leptospirosis Kidney Disease. Cells. 2022;11(4):698. DOI: 10.3390/cells11040698
14. Andrade L, Cleto S, Seguro AC. Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality. Clin J Am Soc Nephrol. 2007;2(4):739-44. DOI: 10.2215/CJN.00680207
15. Maxwell RA, Bell CM. Acute Kidney Injury in the Critically Ill. Surg Clin North Am. 2017;97(6):1399-418. DOI: https://doi.org/10.1016/j.suc.2017.07.004
16. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346(5):305-10. DOI: 10.1056/NEJMoa010877
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Infections in Evidence

This work is licensed under a Creative Commons Attribution 4.0 International License.
The Copyright Transfer Agreement also understands that the authors guarantee that the respective Case Report has never been published in another communication vehicle or scientific journal. Papers presented at meetings and/or scientific congresses may be published in the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, provided that they have not been published in whole or in part in their Proceedings or Annals.